Skip to main content
Premium Trial:

Request an Annual Quote

NIH Calls for Input on Prioritizing Development of Affinity Reagents to Transcription Factors

Premium

The National Institutes of Health this week put out a call for input on a priority list for renewable affinity reagents for human transcription factors.

The outreach is part of the NIIH's Protein Capture Reagents Program, which is intended to determine if a source of high-quality, renewable affinity reagents can be generated and validated for all human proteins and to build technologies for doing so.

As a test case, the program seeks to generate affinity reagents against all human transcription factors.

The program's Target List working group has identified a list of targets to begin production of affinity reagents against and is now seeking input from researchers about the list and assistance in validation of these reagents for a variety of applications and CHiP-seq in particular.

Comments can be contributed through Oct. 31, and can be made here.

The Scan

Study Points to Tuberculosis Protection by Gaucher Disease Mutation

A mutation linked to Gaucher disease in the Ashkenazi Jewish population appears to boost Mycobacterium tuberculosis resistance in a zebrafish model of the lysosomal storage condition, a new PNAS study finds.

SpliceVault Portal Provides Look at RNA Splicing Changes Linked to Genetic Variants

The portal, described in Nature Genetics, houses variant-related messenger RNA splicing insights drawn from RNA sequencing data in nearly 335,700 samples — a set known as the 300K-RNA resource.

Automated Sequencing Pipeline Appears to Allow Rapid SARS-CoV-2 Lineage Detection in Nevada Study

Researchers in the Journal of Molecular Diagnostics describe and assess a Clear Labs Dx automated workflow, sequencing, and bioinformatic analysis method for quickly identifying SARS-CoV-2 lineages.

UK Team Presents Genetic, Epigenetic Sequencing Method

Using enzymatic DNA preparation steps, researchers in Nature Biotechnology develop a strategy for sequencing DNA, along with 5-methylcytosine and 5-hydroxymethylcytosine, on existing sequencers.